← Back to headlines

Eli Lilly leverages GLP-1 success, Honeywell divests unit
Eli Lilly is capitalizing on its GLP-1 drug windfall, while Honeywell is shedding a lower-margin business unit, as part of daily market updates from the Investing Club.
20 Apr, 18:26 — 20 Apr, 18:26
Sources
Showing 1 of 1 sources


